摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6β-hydroxysinomenine | 478064-44-7

中文名称
——
中文别名
——
英文名称
6β-hydroxysinomenine
英文别名
ent-3,7-dimethoxy-17-methyl-morphin-7-ene-4,6α-diol;ent-3,7-Dimethoxy-17-methyl-morphin-7-en-4,6α-diol;β-hydroxy-sinomenine;Sinomeninol-B
6β-hydroxysinomenine化学式
CAS
478064-44-7
化学式
C19H25NO4
mdl
——
分子量
331.412
InChiKey
KKXRIHVJLRZHGU-UMCXVIDHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.81
  • 重原子数:
    24.0
  • 可旋转键数:
    2.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    62.16
  • 氢给体数:
    2.0
  • 氢受体数:
    5.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6β-hydroxysinomenine 在 palladium 10% on activated carbon 、 氢气 作用下, 以 甲醇 为溶剂, 反应 12.0h, 生成 6β-hydroxy-7,8-dihydrosinomenine
    参考文献:
    名称:
    Synthesis, characterization, and NF-κB pathway inhibition of 1-halogenated sinomenine derivatives
    摘要:
    设计并合成了一系列1-卤代紫草素衍生物。所有合成的衍生物均通过ESI-MS和PMR进行了结构确认。在体外评估了衍生物对NF-κB通路的抑制作用,使用了pNF-κB-luc细胞系。衍生物5b、6a、6c和7a的NF-κB活性抑制效果,其IC50值低于紫草素。
    DOI:
    10.1007/s10600-013-0457-8
  • 作为产物:
    描述:
    青藤碱四氢呋喃 、 lithium aluminium tetrahydride 作用下, 生成 6β-hydroxysinomenine
    参考文献:
    名称:
    Liquid–liquid phase separation and crystallization behavior of poly(ethylene terephthalate)/poly(ether imide) blend
    摘要:
    The liquid-liquid (L-L) phase separation and crystallization behavior of poly(ethylene terephthalate) (PET)/poly(ether imide) (PEI) blend were investigated with optical microscopy, light scattering, and small angle X-ray scattering (SAXS). The thermal analysis showed that the concentration fluctuation between separated phases was controllable by changing the time spent for demixing before crystallization. The L-L phase-separated specimens at 130 C for various time periods were subjected to a temperature-jump of 180 C for the isothermal crystallization and then effects of L-L phase separation on crystallization were investigated. The crystal growth rate decreased with increasing L-L phase-separated time (t(s)). The slow crystallization for a long t(s) implied that the growth path of crystals was highly distorted by the rearrangement of the spinodal domains associated with coarsening. The characteristic morphological parameters at the lamellar level were determined by the correlation function analysis on the SAXS data. The blend had a larger amorphous layer thickness than the pure PET, indicating that PEI molecules in the PET-rich phase were incorporated into the interlamellar regions during crystallization. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0032-3861(02)00054-x
点击查看最新优质反应信息

文献信息

  • Synthesis and Anti-Inflammatory Effect of Sinomenine 4-Hydroxy Esters
    作者:Dan Wang、Rong Zhang、Chunbao Jiang、Aun Raza、Jian Tang、Zhen Ouyang、Zhaoliang Su、Huaxi Xu
    DOI:10.1007/s10600-018-2275-5
    日期:2018.1
    In order to find more active anti-neuroinflammatory sinomenine derivatives, 17 sinomenine 4-hydroxy esters were designed and prepared. All synthesized derivatives were structurally confirmed by ESI-MS and PMR. Their anti-neuroinflammatory effects were evaluated using LPS-stimulated BV-2 microglia cells. Among them, four compounds presented more than 80% of cell viability. Compound 8 showed remarkable
    为了寻找更具活性的抗神经炎症的青藤碱生物,设计并制备了17种青藤碱4-羟基酯。所有合成的衍生物均通过 ESI-MS 和 PMR 进行结构确认。使用 LPS 刺激的 BV-2 小胶质细胞评估它们的抗神经炎症作用。其中,四种化合物呈现超过 80% 的细胞活力。通过 Griess 方法,化合物 8 显示出对一氧化氮 (NO) 释放的显着抑制。此外,测试了酯 5-9 以检查它们对二甲苯引起的耳肿的抑制作用。据观察,8 比具有较短脂肪链的 5-7 更具活性且毒性更小。
  • Process for the Preparation of 6-Beta Hydroxy Morphinan Compounds
    申请人:Bao Jian
    公开号:US20090312552A1
    公开(公告)日:2009-12-17
    The invention provides processes for the conversion of a 6-keto morphinan to a 6-hydroxy morphinan. In particular, the invention provides a stereoselective process for the conversion of a 6-keto morphinan to a 6-beta-hydroxy morphinan.
    该发明提供了将6-酮吗啡烷转化为6-羟基吗啡烷的过程。具体地,该发明提供了一种立体选择性的过程,用于将6-酮吗啡烷转化为6-β-羟基吗啡烷。
  • Goto; Yamamoto, Journal of the Agricultural Chemical Society of Japan, 1955, vol. 19, p. 110,119
    作者:Goto、Yamamoto
    DOI:——
    日期:——
查看更多